Cite
ASSESSMENT OF THE DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS BETWEEN FOUR DISTINCT FORMULATIONS OF TRIAMCINOLONE ACETONIDE
MLA
Y. Li, et al. “Assessment of the Differences in Pharmacokinetics and Pharmacodynamics between Four Distinct Formulations of Triamcinolone Acetonide.” Retina, vol. 33, Mar. 2013, pp. 522–31. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9dbb7e6241d1d5854ee1dddcf14d1956&authtype=sso&custid=ns315887.
APA
Y. Li, Baruch D. Kuppermann, Barbara Feldmann, Guadalupe Ruiz, James R. Burke, Werhner C. Orilla, Ton Lin, Rafael Migon, Leandro Cabral Zacharias, & Corine Ghosn. (2013). Assessment of the Differences in Pharmacokinetics and Pharmacodynamics between Four Distinct Formulations of Triamcinolone Acetonide. Retina, 33, 522–531.
Chicago
Y. Li, Baruch D. Kuppermann, Barbara Feldmann, Guadalupe Ruiz, James R. Burke, Werhner C. Orilla, Ton Lin, Rafael Migon, Leandro Cabral Zacharias, and Corine Ghosn. 2013. “Assessment of the Differences in Pharmacokinetics and Pharmacodynamics between Four Distinct Formulations of Triamcinolone Acetonide.” Retina 33 (March): 522–31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9dbb7e6241d1d5854ee1dddcf14d1956&authtype=sso&custid=ns315887.